Article
Using genomics to guide treatment for glioblastoma.
Pharmacogenomics - 1 Oct 2018
Young Jacob S, Prados Michael D, Butowski Nicholas
Abstract excerpt
Glioblastoma has been shown to have many different genetic mutations found both within and between tumor samples. Molecular testing and genomic sequencing has helped to classify diagnoses and clarify difficult to interpret histopathological specimens. Genomic information also plays a critical role in prognostication for patients, with IDH mutations and MGMT methylation having significant impact of the response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
